Pacylex News has migrated to Newsroom. Click the link below to access the latest articles and press releases.

Visit Newsroom
01 Pacylex News

Past Articles

June 15, 2021

Pacylex Presents Updates on the Journey of PCLX-001 to the Clinic at BIO and FASEB Conferences

Pacylex will present updates on the journey of PCLX-001 to the Clinic at the Annual BIO Meeting and the summer FASEB conference on protein lipidation.

June 2, 2021

Pacylex Pharmaceuticals Closes Series A Funding to Advance Oncology Program into the Clinic

Pacylex Pharmaceuticals and Greenfire Bio announced the closing of Series A financing for Pacylex. These funds will be used to support the initial Phase 1 clinical investigation of PCLX-001 in multiple cancers.

March 20, 2021

Pacylex CEO Michael Weickert named a CEO To Watch

March 11, 2021

Health Canada Approves PCLX-001 Phase I Clinical Trial

January 6, 2021

Publication in "Breast Cancer Research and Treatment"

November 23, 2020

Pacylex CEO Michael Weickert interviewed for CEO CFO Magazine

November 4, 2020

Fierce Biotech covers Pacylex Pharmaceuticals' recent progress

November 4, 2020

Targeting N-myristoyltransferases in cancer: when the end justifies the means

October 22, 2020

Pacylex Pharmaceuticals Announces Publication in Nature Communications of a New Target for Therapeutic Intervention in Hematologic Malignancies and Preclinical Results of a First-in-Class Therapy

Pacylex: Targeting myristoylation to selectively kill cancer.

info@pacylex.com

Navigation
HomeAboutTeamPipelineNewsContact
Connect With Us
FacebookLinkedIn
Copyright © 2024 Pacylex Pharmaceuticals Inc.
Icon Attribution - Icons8
Fairway Inc.
Edmonton Web Design